Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Docetaxel|OTHER: Placebo|DRUG: Indoximod|DRUG: Paclitaxel
Sponsor: NewLink Genetics Corporation